Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Study Confirms Actos Bladder Cancer Danger, Again

Filed August 15th, 2012 Laurie

A new study published online this month in the Journal of the National Cancer Institute says a popular class of diabetes drugs, known as thiazolidinedione (TZDs), increases patients’ risk of developing bladder cancer.

TZDs, including the drug Actos, account for about 20 percent of the drugs prescribed to patients in the U.S. According to the study, patients taking these drugs are two to three times more likely to develop bladder cancer than those who take sulfonylurea drugs.
Patients with diabetes already have a slightly higher chance of bladder cancer than the general population. Among the general population, about 30 in 100,000 people develop bladder cancer, and about 40 in 100,000 people with diabetes develop the disease.

The study found that in patients taking Actos or other TZDs, approximately 170 in 100,000 would be expected to develop the disease. About 60 in 100,000 patients taking sulfonylurea drugs would be expected to develop bladder cancer.

The Food and Drug Administration has already warned that Actos may be associated with an increased risk of bladder cancer, and France and Germany have removed the drug from the market.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!